恆大(03333.HK):穗深政府斥300億人幣接手恆大地產股權
中國恆大(03333.HK)公布,持有恆大地產1,300億元人民幣(下同)股權的戰略投資者中,除早前有863億元權益已完成轉為普通股外,是次有394億元權益已簽訂補充協議,合共有1,257億元的戰略投資者已簽訂協議,同意將股份轉為普通股。剩餘43億人民幣權益戰略投資者的本金已由集團現金支付後回購。
已簽訂補充協議的戰略投資者中,200億元權益由深圳市國資委旗下深圳市人才安居集團有限公司持有,100億元權益則由廣州市政府旗下的廣州市城投投資有限公司持有,94億元權益由深圳市人民政府全資擁有的深業集團有限公司及其他原戰略投資者繼續持有。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.